{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:30Z","timestamp":1781636070061,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GlaxoSmithKline foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT220221\/Z\/20\/Z"],"award-info":[{"award-number":["WT220221\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT203148\/Z\/16\/Z"],"award-info":[{"award-number":["WT203148\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT084052\/Z\/07\/Z"],"award-info":[{"award-number":["WT084052\/Z\/07\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT212885\/Z\/18\/Z"],"award-info":[{"award-number":["WT212885\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/L015226\/1"],"award-info":[{"award-number":["EP\/L015226\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S032789\/1"],"award-info":[{"award-number":["EP\/S032789\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C63178\/A24959"],"award-info":[{"award-number":["C63178\/A24959"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7893\/A28990"],"award-info":[{"award-number":["C7893\/A28990"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X00841X\/1"],"award-info":[{"award-number":["MR\/X00841X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tumour-associated macrophages are highly abundant in the tumour microenvironment, and their levels influence tumour progression and therapy response. Tracking macrophages by positron-emission tomography (PET) can yield critical information on the dynamics of macrophage infiltration, particularly in diseases such as breast cancer, in which tumour-associated macrophages are significant in the evolution of the tumour microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two complementary PET imaging methods were used to track macrophages. The first method used a novel [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-labelled antibody that targets the murine F4\/80 receptor, which is located on the cell surface of\n                      <jats:italic>in situ<\/jats:italic>\n                      macrophages. [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-DFO-anti-F4\/80 and a non-specific [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-labelled control antibody were developed and characterised for their specificity. The second method involved directly labelling mouse-derived macrophages with [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-oxine, and the effect of [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-radiolabelling on macrophage viability and phenotype was evaluated. Using PET imaging and\n                      <jats:italic>ex vivo<\/jats:italic>\n                      tissue counting, the in vivo biodistribution of [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-DFO-anti-F4\/80 and [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-labelled murine macrophages was quantified in female BALB\/c mice bearing syngeneic, orthotopic 4T1 breast cancer tumours.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-DFO-anti-F4\/80 showed target-specific uptake\n                      <jats:italic>in vitro<\/jats:italic>\n                      . At a dose of 100 \u03bcg DFO-anti-F4\/80 per mouse, [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-DFO-anti-F4\/80 enabled visualization of tumour-resident macrophages by PET\/CT with high contrast. This was not observed for non-specific [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-DFO-IgG2b. PET\/CT imaging showed that intravenously administered [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-labelled M0 macrophages migrated to the liver and spleen, with a proportion of macrophages trafficking to the tumour. [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-oxine labelling did not affect macrophage viability nor phenotype, even at an absorbed radiation dose of 3.31\u00a0Gy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      For the first time, we have applied and compared two complementary PET\/CT imaging strategies to quantify the infiltration of macrophages in an orthotopic, syngeneic murine model of breast cancer. First, PET\/CT imaging using an \u201cindirect\u201d cell tracking approach with a new [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-DFO-anti-F4\/80 antibody radiotracer showed that resident tumour-associated macrophages are abundant in this syngeneic breast cancer model. Second, PET\/CT imaging using [\n                      <jats:sup>89<\/jats:sup>\n                      Zr]Zr-labelled M0 macrophages showed that macrophages in the blood pool migrate to the tumour, within 24\u00a0h. These tools have utility in quantifying macrophage distribution and migration in cancer, particularly in the context of new and existing therapies in which macrophage populations are perturbed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-025-07752-8","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:03:44Z","timestamp":1770962624000},"page":"4130-4142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tracking macrophages by direct and indirect 89Zr PET imaging"],"prefix":"10.1007","volume":"53","author":[{"given":"Vittorio","family":"De Santis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshiya","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Langdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truc T.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Carrascal-Mini\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Sunassee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael T. M.","family":"De Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Witney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle T.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6497-6681","authenticated-orcid":false,"given":"Samantha Y. A.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"7752_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217.","journal-title":"Nat Rev Clin Oncol"},{"key":"7752_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MCP.0000000000000647","volume":"26","author":"TA van der Veen","year":"2020","unstructured":"van der Veen TA, de Groot LES, Melgert BN. The different faces of the macrophage in asthma. Curr Opin Pulm Med. 2020;26:62\u20138. https:\/\/doi.org\/10.1097\/MCP.0000000000000647.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"7752_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57841-x","volume":"10","author":"NJF Verweij","year":"2020","unstructured":"Verweij NJF, Yaqub M, Bruijnen STG, Pieplenbosch S, Ter Wee MM, Jansen G, et al. First in man study of [(18)F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis. Sci Rep. 2020;10(1):1047. https:\/\/doi.org\/10.1038\/s41598-020-57841-x.","journal-title":"Sci Rep"},{"key":"7752_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030464","author":"M Finicelli","year":"2022","unstructured":"Finicelli M, Digilio FA, Galderisi U, Peluso G. The emerging role of macrophages in chronic obstructive pulmonary disease: the potential impact of oxidative stress and extracellular vesicle on macrophage polarization and function. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11030464.","journal-title":"Antioxidants"},{"key":"7752_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","volume":"18","author":"M Kurowska-Stolarska","year":"2022","unstructured":"Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Rev Rheumatol. 2022;18:384\u201397. https:\/\/doi.org\/10.1038\/s41584-022-00790-8.","journal-title":"Nat Rev Rheumatol"},{"key":"7752_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep27548","volume":"6","author":"M Okubo","year":"2016","unstructured":"Okubo M, Kioi M, Nakashima H, Sugiura K, Mitsudo K, Aoki I, et al. M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation. Sci Rep. 2016;6:27548. https:\/\/doi.org\/10.1038\/srep27548.","journal-title":"Sci Rep"},{"key":"7752_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15:73\u201386. https:\/\/doi.org\/10.1038\/nri3789.","journal-title":"Nat Rev Immunol"},{"key":"7752_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014.","journal-title":"Cell"},{"key":"7752_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221076194","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Wang R, Zhang Y, Han S, Gan Y, Liang Q, et al. Molecular imaging of tumor-associated macrophages in cancer immunotherapy. Ther Adv Med Oncol. 2022;14:17588359221076194. https:\/\/doi.org\/10.1177\/17588359221076194.","journal-title":"Ther Adv Med Oncol"},{"key":"7752_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell. 2015;27:462\u201372. https:\/\/doi.org\/10.1016\/j.ccell.2015.02.015.","journal-title":"Cancer Cell"},{"key":"7752_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1158\/0008-5472.CAN-20-1885","volume":"81","author":"L La Fleur","year":"2021","unstructured":"La Fleur L, Botling J, He F, Pelicano C, Zhou C, He C, et al. Targeting MARCO and IL37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function. Cancer Res. 2021;81:956\u201367. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1885.","journal-title":"Cancer Res"},{"key":"7752_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717\u201334. https:\/\/doi.org\/10.1038\/nrclinonc.2017.101.","journal-title":"Nat Rev Clin Oncol"},{"key":"7752_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","volume":"131","author":"JH Rannikko","year":"2024","unstructured":"Rannikko JH, Hollmen M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br J Cancer. 2024;131:627\u201340. https:\/\/doi.org\/10.1038\/s41416-024-02715-6.","journal-title":"Br J Cancer"},{"key":"7752_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/1536012116689499","volume":"16","author":"C Jiang","year":"2017","unstructured":"Jiang C, Cai H, Peng X, Zhang P, Wu X, Tian R. Targeted imaging of tumor-associated macrophages by Cyanine 7-labeled mannose in xenograft tumors. Mol Imaging. 2017;16:1536012116689499. https:\/\/doi.org\/10.1177\/1536012116689499.","journal-title":"Mol Imaging"},{"key":"7752_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.7150\/thno.11546","volume":"5","author":"X Sun","year":"2015","unstructured":"Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B, et al. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer. Theranostics. 2015;5:597\u2013608. https:\/\/doi.org\/10.7150\/thno.11546.","journal-title":"Theranostics"},{"key":"7752_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00783","volume":"8","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Zeng Y, Xu Y, Xiao X, Liu H, Zhou B, et al. Ultrasound molecular imaging as a potential non-invasive diagnosis to detect the margin of hepatocarcinoma via CSF-1R targeting. Front Bioeng Biotechnol. 2020;8:783. https:\/\/doi.org\/10.3389\/fbioe.2020.00783.","journal-title":"Front Bioeng Biotechnol"},{"key":"7752_CR17","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.2147\/IJN.S238587","volume":"15","author":"X Sun","year":"2020","unstructured":"Sun X, Guo L, Shang M, Shi D, Liang P, Jing X, et al. Ultrasound mediated destruction of LMW-HA-loaded and folate-conjugated nanobubble for TAM targeting and reeducation. Int J Nanomedicine. 2020;15:1967\u201381. https:\/\/doi.org\/10.2147\/IJN.S238587.","journal-title":"Int J Nanomedicine"},{"key":"7752_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nmat3780","volume":"13","author":"R Weissleder","year":"2014","unstructured":"Weissleder R, Nahrendorf M, Pittet MJ. Imaging macrophages with nanoparticles. Nat Mater. 2014;13:125\u201338. https:\/\/doi.org\/10.1038\/nmat3780.","journal-title":"Nat Mater"},{"key":"7752_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00590","volume":"8","author":"NJ Serkova","year":"2017","unstructured":"Serkova NJ. Nanoparticle-based magnetic resonance imaging on tumor-associated macrophages and inflammation. Front Immunol. 2017;8:590. https:\/\/doi.org\/10.3389\/fimmu.2017.00590.","journal-title":"Front Immunol"},{"key":"7752_CR20","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2967\/jnumed.124.267876","volume":"65","author":"TT Pham","year":"2024","unstructured":"Pham TT, Chenoweth A, Patel N, Banu A, Osborn G, Blower PJ, et al. In vivo PET imaging of (89)Zr-labeled natural killer cells and the modulating effects of a therapeutic antibody. J Nucl Med. 2024;65:1035\u201342. https:\/\/doi.org\/10.2967\/jnumed.124.267876.","journal-title":"J Nucl Med"},{"key":"7752_CR21","doi-asserted-by":"publisher","unstructured":"Man F, Khan AA, Carrascal-Minino A, Blower PJ, R TMdR. A kit formulation for the preparation of [(89)Zr]Zr(oxinate)(4) for PET cell tracking: White blood cell labelling and comparison with [(111)In]In(oxinate)(3). Nucl Med Biol. 2020;90\u201391:31\u201340. https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.09.002.","DOI":"10.1016\/j.nucmedbio.2020.09.002"},{"key":"7752_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ymthe.2018.10.006","volume":"27","author":"F Man","year":"2019","unstructured":"Man F, Lim L, Volpe A, Gabizon A, Shmeeda H, Draper B, et al. In Vivo PET tracking of (89)Zr-labeled Vgamma9Vdelta2 T cells to mouse xenograft breast tumors activated with liposomal alendronate. Mol Ther. 2019;27:219\u201329. https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.006.","journal-title":"Mol Ther"},{"key":"7752_CR23","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2242559\/v1","author":"P Leland","year":"2023","unstructured":"Leland P, Kumar D, Nimaggada S, Bauer SR, Puri RK, Joshi BH. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Ralpha2 after radiolabeling with 89Zirconium oxine for PET imaging. Res Sq. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2242559\/v1.","journal-title":"Res Sq"},{"key":"7752_CR24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2967\/jnumed.115.156828","volume":"56","author":"A Blykers","year":"2015","unstructured":"Blykers A, Schoonooghe S, Xavier C, D\u2019Hoe K, Laoui D, D\u2019Huyvetter M, et al. PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments. J Nucl Med. 2015;56:1265\u201371. https:\/\/doi.org\/10.2967\/jnumed.115.156828.","journal-title":"J Nucl Med"},{"key":"7752_CR25","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2967\/jnumed.120.255760","volume":"62","author":"P Guzik","year":"2021","unstructured":"Guzik P, Fang HY, Deberle LM, Benesova M, Cohrs S, Boss SD, et al. Identification of a PET radiotracer for imaging of the folate receptor-alpha: a potential tool to select patients for targeted tumor therapy. J Nucl Med. 2021;62:1475\u201381. https:\/\/doi.org\/10.2967\/jnumed.120.255760.","journal-title":"J Nucl Med"},{"key":"7752_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/s0969-8051(03)00080-5","volume":"30","author":"CJ Mathias","year":"2003","unstructured":"Mathias CJ, Lewis MR, Reichert DE, Laforest R, Sharp TL, Lewis JS, et al. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol. 2003;30:725\u201331. https:\/\/doi.org\/10.1016\/s0969-8051(03)00080-5.","journal-title":"Nucl Med Biol"},{"key":"7752_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70394-3","volume":"10","author":"O Moisio","year":"2020","unstructured":"Moisio O, Palani S, Virta J, Elo P, Liljenback H, Tolvanen T, et al. Radiosynthesis and preclinical evaluation of [68Ga]Ga-NOTA-folate for PET imaging of folate receptor \u03b2-positive macrophages. Sci Rep. 2020;10:13593. https:\/\/doi.org\/10.1038\/s41598-020-70394-3.","journal-title":"Sci Rep"},{"key":"7752_CR28","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1016\/j.biomaterials.2012.07.022","volume":"33","author":"LW Locke","year":"2012","unstructured":"Locke LW, Mayo MW, Yoo AD, Williams MB, Berr SS. PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes. Biomaterials. 2012;33:7785\u201393. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.07.022.","journal-title":"Biomaterials"},{"key":"7752_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2967\/jnumed.115.158956","volume":"56","author":"C Perez-Medina","year":"2015","unstructured":"Perez-Medina C, Tang J, Abdel-Atti D, Hogstad B, Merad M, Fisher EA, et al. Pet imaging of tumor-associated macrophages with 89Zr-labeled high-density lipoprotein nanoparticles. J Nucl Med. 2015;56:1272\u20137. https:\/\/doi.org\/10.2967\/jnumed.115.158956.","journal-title":"J Nucl Med"},{"key":"7752_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s44303-024-00009-3","volume":"2","author":"YC Toner","year":"2024","unstructured":"Toner YC, Prevot G, van Leent MMT, Munitz J, Oosterwijk R, Verschuur AVD, et al. Macrophage PET imaging in mouse models of cardiovascular disease and cancer with an apolipoprotein-inspired radiotracer. Npj Imaging. 2024;2:12. https:\/\/doi.org\/10.1038\/s44303-024-00009-3.","journal-title":"Npj Imaging"},{"key":"7752_CR31","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.4049\/jimmunol.1402005","volume":"195","author":"AK Azad","year":"2015","unstructured":"Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, et al. \u03b3-Tilmanocept, a new radiopharmaceutical tracer for cancer sentinel lymph nodes, binds to the mannose receptor (CD206). J Immunol. 2015;195:2019\u201329. https:\/\/doi.org\/10.4049\/jimmunol.1402005.","journal-title":"J Immunol"},{"key":"7752_CR32","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.7150\/thno.47269","volume":"11","author":"C Foray","year":"2021","unstructured":"Foray C, Valtorta S, Barca C, Winkeler A, Roll W, Muther M, et al. Imaging temozolomide-induced changes in the myeloid glioma microenvironment. Theranostics. 2021;11:2020\u201333. https:\/\/doi.org\/10.7150\/thno.47269.","journal-title":"Theranostics"},{"key":"7752_CR33","doi-asserted-by":"publisher","first-page":"546","DOI":"10.7150\/thno.8159","volume":"4","author":"C Wu","year":"2014","unstructured":"Wu C, Yue X, Lang L, Kiesewetter DO, Li F, Zhu Z, et al. Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors. Theranostics. 2014;4:546\u201355. https:\/\/doi.org\/10.7150\/thno.8159.","journal-title":"Theranostics"},{"key":"7752_CR34","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/neuonc\/noaa023","volume":"22","author":"B Zinnhardt","year":"2020","unstructured":"Zinnhardt B, Muther M, Roll W, Backhaus P, Jeibmann A, Foray C, et al. Tspo imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma. Neuro Oncol. 2020;22:1030\u201343. https:\/\/doi.org\/10.1093\/neuonc\/noaa023.","journal-title":"Neuro Oncol"},{"key":"7752_CR35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s00259-019-04491-5","volume":"47","author":"M Unterrainer","year":"2020","unstructured":"Unterrainer M, Fleischmann DF, Vettermann F, Ruf V, Kaiser L, Nelwan D, et al. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative (18)F-GE-180 PET study. Eur J Nucl Med Mol Imaging. 2020;47:1368\u201380. https:\/\/doi.org\/10.1007\/s00259-019-04491-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1293\u2013308","key":"7752_CR36","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi E, Carr AJ, Plitas G, Cornish AE, Konopacki C, Prabhakaran S, et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell. 2018;174(1293\u2013308):e36. https:\/\/doi.org\/10.1016\/j.cell.2018.05.060.","journal-title":"Cell"},{"key":"7752_CR37","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s00259-015-3084-8","volume":"42","author":"SY Terry","year":"2015","unstructured":"Terry SY, Boerman OC, Gerrits D, Franssen GM, Metselaar JM, Lehmann S, et al. 111In-anti-F4\/80-A3-1 antibody: a novel tracer to image macrophages. Eur J Nucl Med Mol Imaging. 2015;42:1430\u20138. https:\/\/doi.org\/10.1007\/s00259-015-3084-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7752_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acs.bioconjchem.1c00597","volume":"33","author":"AA Khan","year":"2022","unstructured":"Khan AA, Man F, Faruqu FN, Kim J, Al-Salemee F, Carrascal-Minino A, et al. PET imaging of small extracellular vesicles via [(89)Zr]Zr(oxinate)(4) direct radiolabeling. Bioconjug Chem. 2022;33:473\u201385. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00597.","journal-title":"Bioconjug Chem"},{"key":"7752_CR39","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11:723\u201337. https:\/\/doi.org\/10.1038\/nri3073.","journal-title":"Nat Rev Immunol"},{"key":"7752_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/00003072-197803000-00008","volume":"3","author":"PW Doherty","year":"1978","unstructured":"Doherty PW, Bushberg JT, Lipton MJ, Meares CF, Goodwin DA. The use of indium-111-labeled leukocytes for abscess detection. Clin Nucl Med. 1978;3:108\u201310. https:\/\/doi.org\/10.1097\/00003072-197803000-00008.","journal-title":"Clin Nucl Med"},{"key":"7752_CR41","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0969-8051(95)00013-n","volume":"22","author":"R Audran","year":"1995","unstructured":"Audran R, Collet B, Moisan A, Toujas L. Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously. Nucl Med Biol. 1995;22:817\u201321. https:\/\/doi.org\/10.1016\/0969-8051(95)00013-n.","journal-title":"Nucl Med Biol"},{"key":"7752_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00655-9","volume":"10","author":"S Belderbos","year":"2020","unstructured":"Belderbos S, Gonzalez-Gomez MA, Cleeren F, Wouters J, Pineiro Y, Deroose CM, et al. Simultaneous in vivo PET\/MRI using fluorine-18 labeled Fe(3)O(4)@Al(OH)(3) nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution. EJNMMI Res. 2020;10:73. https:\/\/doi.org\/10.1186\/s13550-020-00655-9.","journal-title":"EJNMMI Res"},{"key":"7752_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002108","author":"N Verweij","year":"2022","unstructured":"Verweij N, Zwezerijnen G, Ter Wee M, de Jongh J, Yaqub M, van Schaardenburg D, et al. Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET. RMD Open. 2022. https:\/\/doi.org\/10.1136\/rmdopen-2021-002108.","journal-title":"RMD Open"},{"key":"7752_CR44","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3899\/jrheum.210928","volume":"49","author":"NJF Verweij","year":"2022","unstructured":"Verweij NJF, de Jongh J, Wee MMT, Zwezerijnen GJC, Yaqub M, Voskuyl AE, et al. Whole-body macrophage positron emission tomography imaging for disease activity assessment in early rheumatoid arthritis. J Rheumatol. 2022;49:871\u20137. https:\/\/doi.org\/10.3899\/jrheum.210928.","journal-title":"J Rheumatol"},{"key":"7752_CR45","first-page":"69","volume":"62","author":"S Denham","year":"1987","unstructured":"Denham S, Barfoot R, Jackson E. A receptor for monomeric IgG2b on rat macrophages. Immunology. 1987;62:69\u201374.","journal-title":"Immunology"},{"key":"7752_CR46","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1158\/0008-5472.CAN-11-2994","volume":"72","author":"K Movahedi","year":"2012","unstructured":"Movahedi K, Schoonooghe S, Laoui D, Houbracken I, Waelput W, Breckpot K, et al. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Res. 2012;72:4165\u201377. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2994.","journal-title":"Cancer Res"},{"key":"7752_CR47","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nucmedbio.2010.12.011","volume":"38","author":"DS Abou","year":"2011","unstructured":"Abou DS, Ku T, Smith-Jones PM. In vivo biodistribution and accumulation of 89Zr in mice. Nucl Med Biol. 2011;38:675\u201381. https:\/\/doi.org\/10.1016\/j.nucmedbio.2010.12.011.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"7752_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00259-014-2945-x","volume":"42","author":"P Charoenphun","year":"2015","unstructured":"Charoenphun P, Meszaros LK, Chuamsaamarkkee K, Sharif-Paghaleh E, Ballinger JR, Ferris TJ, et al. [89Zr]oxinate4 for long-term in vivo cell tracking by positron emission tomography. Eur J Nucl Med Mol Imaging. 2015;42(2):278\u201387. https:\/\/doi.org\/10.1007\/s00259-014-2945-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7752_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7150\/ntno.51391","volume":"5","author":"Y Kurebayashi","year":"2021","unstructured":"Kurebayashi Y, Choyke PL, Sato N. Imaging of cell-based therapy using (89)Zr-oxine ex vivo cell labeling for positron emission tomography. Nanotheranostics. 2021;5:27\u201335. https:\/\/doi.org\/10.7150\/ntno.51391.","journal-title":"Nanotheranostics"},{"key":"7752_CR50","first-page":"20","volume":"51","author":"A Hammers","year":"2025","unstructured":"Hammers A, Terry S. Total body PET imaging: the changing radionuclide imaging landscape in the UK. RAD Mag. 2025;51:20\u20131.","journal-title":"RAD Mag"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07752-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:12:34Z","timestamp":1781633554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07752-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7752"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07752-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed in accordance with the Animals (Scientific Procedures) Act. 1986, with protocols approved by UK Home Office and King\u2019s College London animal welfare and ethical review body (St Thomas\u2019 Campus) under Home Office Project Licenses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}